Evidence map›Paper›PMID 27869790›Full record

ArticleNature microbiology2016

The genome of Onchocerca volvulus, agent of river blindness.

James A Cotton, Sasisekhar Bennuru, Alexandra Grote, Bhavana Harsha, Alan Tracey, Robin Beech, Stephen R Doyle, Matthew Dunn, Julie C Dunning Hotopp, Nancy Holroyd and 17 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 146 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Chromosome-contiguous nuclear genome ofOne health (Amsterdam, Netherlands) · 2025
    Article
  6. Article
  7. Article
  8. Fexinidazole and Corallopyronin A targetbioRxiv : the preprint server for biology · 2025
    Article
  9. Inference of essential genes inComputational and structural biotechnology journal · 2024
    Article
  10. Article
  11. Article
  12. Comparative development of human filariaeFrontiers in tropical diseases · 2024
    Article
  13. AdvancingPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. AssessingPathogens (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 3 countries.

James A CottonWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.ORCID http://orcid.org/0000-0001-5475-3583
Sasisekhar BennuruLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892, USA.ORCID http://orcid.org/0000-0002-6117-742X
Alexandra GroteCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, New York 10003, USA.
Bhavana HarshaWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Alan TraceyWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Robin BeechInstitute of Parasitology, McGill University, Montreal, Quebec H9X 3V9, Canada.
Stephen R DoyleWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.ORCID http://orcid.org/0000-0001-9167-7532
Matthew DunnWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Julie C Dunning HotoppInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Nancy HolroydWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Taisei KikuchiWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Olivia LambertWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Amruta MhashilkarGlobal Health Infectious Disease Research Program, Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida 33612, USA.
Prudence MutowoEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
Nirvana NursimuluDepartment of Computer Science, University of Toronto, Toronto M5S 3G4, Canada.
Jose M C RibeiroLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892, USA.
Matthew B RogersChildren's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15224, USA.
Eleanor StanleyWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Lakshmipuram S SwapnaDivision of Molecular Structure and Function, Research Institute, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Isheng J TsaiWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.ORCID http://orcid.org/0000-0002-2123-5058
Thomas R UnnaschGlobal Health Infectious Disease Research Program, Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida 33612, USA.
Denis VoroninNew York Blood Center, New York, New York 10065, USA.
John ParkinsonDepartment of Computer Science, University of Toronto, Toronto M5S 3G4, Canada.
Thomas B NutmanLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892, USA.ORCID http://orcid.org/0000-0001-6887-4941
Elodie GhedinCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, New York 10003, USA.
Matthew BerrimanWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.ORCID http://orcid.org/0000-0002-9581-0377
Sara LustigmanNew York Blood Center, New York, New York 10065, USA.
Wellcome Sanger Institute · GBNational Institute of Allergy and Infectious Diseases · USNew York Blood Center · USNew York University · USUniversity of South Florida · USUniversity of Toronto · CAEuropean Bioinformatics Institute · GBHospital for Sick Children · CAHuman Genome Sciences (United States) · USMcGill University · CAUniversity of Pittsburgh · US

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, OWEN R · 2014 to 2023
$36.5M
Vector-Borne Diseases: Biology Of Vector Host RelationshipZIAAI000810 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI RIBEIRO, JOSE · 2009 to 2025
$20.8M
Molecular Definition Of Filarial And Related Nonfilarial Genes And ProteinsZIAAI000512 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$9.9M
INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
The development of a recombinant vaccine against human onchocerciasisR01AI078314 · NIAID · NEW YORK BLOOD CENTER · PI LUSTIGMAN, SARA · 2009 to 2021
$7.0M
Impact of Bacterial-Animal Lateral Gene Transfer on Human HealthDP2OD007372 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI DUNNING HOTOPP, JULIE · 2010 to 2010
$2.3M
NIAID NIH HHS R01 AI078314NIAID NIH HHS T32 AI007180NIAID NIH HHS U19 AI110820NIH HHS DP2 OD007372Wellcome Trust
6 · The paper itself

Abstract

Human onchocerciasis is a serious neglected tropical disease caused by the filarial nematode Onchocerca volvulus that can lead to blindness and chronic disability. Control of the disease relies largely on mass administration of a single drug, and the development of new drugs and vaccines depends on a better knowledge of parasite biology. Here, we describe the chromosomes of O. volvulus and its Wolbachia endosymbiont. We provide the highest-quality sequence assembly for any parasitic nematode to date, giving a glimpse into the evolution of filarial parasite chromosomes and proteomes. This resource was used to investigate gene families with key functions that could be potentially exploited as targets for future drugs. Using metabolic reconstruction of the nematode and its endosymbiont, we identified enzymes that are likely to be essential for O. volvulus viability. In addition, we have generated a list of proteins that could be targeted by Federal-Drug-Agency-approved but repurposed drugs, providing starting points for anti-onchocerciasis drug development.

Indexed as

Genome, HelminthAnimalsGenome, BacterialOnchocerca volvulusOnchocerciasis, OcularWolbachia

Identifiers

PMID27869790
PMCPMC5310847
OpenAlexW2552031419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.